Abstract-We recently showed that brain mineralocorticoid receptors (MRs) are involved in blood pressure and kidney function control in normotensive Wistar rats. We now assessed the involvement of brain MRs in spontaneously hypertensive rats (SHR), in which the presence of adrenocorticoids has been shown to be required for the development of hypertension. The effect of a single intracerebroventricular (ICV) injection of an MR antagonist (RU28318) on systolic blood pressure (SBP) and renal function was examined in conscious adult SHR and Wistar-Kyoto rats (WKY) maintained on a standard-sodium diet (0.4% Na ϩ ). In WKY, a long-lasting decrease in SBP was caused by the ICV injection of 10 ng RU28318 as previously reported in Wistar rats, associated with increased urinary excretion of water and electrolytes. In SHR maintained on the standard diet, the ICV injection of RU28318 (10 or 100 ng) had no effect on cardiovascular and renal functions. However, the ICV injection of 10 ng RU28318 in SHR after 3 weeks of high sodium intake (8% Na ϩ ) caused a long-lasting decrease in SBP. The effect was present at 8 hours (⌬SBP 34Ϯ2 mm Hg), persisted at 24 hours (⌬SBP 29Ϯ1 mm Hg), and disappeared at 48 hours after the injection. The hypotension was not associated with changes in heart rate, urinary excretion of water and electrolytes, and plasma renin activity, whereas renal denervation did not affect the decrease in SBP. A more pronounced decrease in SBP (49Ϯ3 mm Hg at 8 hours) was observed with 100 ng RU28318. This dose of the antagonist was without effect after subcutaneous administration. Key Words: brain Ⅲ mineralocorticoids Ⅲ rats, inbred SHR Ⅲ sodium Ⅲ rats, inbred WKY S everal lines of evidence suggest that brain mineralocorticoid receptors (MRs) are involved in blood pressure control in hypertension induced by mineralocorticoids but also appear to play a role in cardiovascular control in normotensive animals. [1][2][3][4] In normotensive Wistar rats, we recently showed that selective blockade of brain MRs induced a long-lasting decrease in blood pressure associated with increased diuresis and augmented urinary excretion of electrolytes. 4 The involvement of brain MRs in hypertension was demonstrated in deoxycorticosterone (DOCA)-salt rats as well as in genetic hypertension in Dahl salt-sensitive rats. Intracerebroventricular (ICV) infusion of an MR antagonist inhibited the rise in blood pressure induced by DOCA-salt as well as the development of salt-dependent hypertension in Dahl salt-sensitive rats. 2,5 For spontaneously hypertensive rats (SHR), data are lacking regarding a role of brain MRs in the development or maintenance of hypertension, except for a brief report suggesting refractoriness to high doses of an MR antagonist administered ICV in adult SHR. 6 The pathophysiology of the development of hypertension in SHR so far has not been resolved. However, evidence is substantial for a role of brain mechanisms that cause an early increase in sympathetic nervous activity. 7-9 SHR show enhanced pressor responses to a v...